Basal pepsinogen I levels and Helicobacter pylori infection in patients with duodenal ulcer and normal endoscopy;NIVELES BASALES DE PEPSINOGENO I SERICO E INFECCION POR HELICOBACTER PYLORI EN PACIENTES CON ULCERA DUODENAL Y ENDOSCOPIA NORMAL

Revista Espanola de Enfermedades Digestivas

Volumn 88, Issue 1, 1996, Pages 3-8

  Gisbert, J P ^a,b,f   Boixeda, D ^a,b   Vila, T ^a,c   De Rafael, L ^a,d   Redondo, C ^a,e   Martin Deargila C ^a,b   Arocena, C ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b Servicio de Gastroenterología   (Spain)

^c Servicio de Medicina Nuclear   (Spain)

^d Servicio de Microbiología   (Spain)

^e Serv de Anat Patológica

^f NONE   (Spain)

Author keywords

duodenal ulcer; gastritis; Helicobacter pylori; pepsinogen I

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PEPSINOGEN I; PEPSINOGEN;

ADULT; ARTICLE; ENDOSCOPY; FEMALE; GASTRITIS; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; AGED; BLOOD; COMPARATIVE STUDY; DUODENUM ULCER; HELICOBACTER INFECTION; MIDDLE AGED; STATISTICAL ANALYSIS;

ADULT; AGED; DATA INTERPRETATION, STATISTICAL; DUODENAL ULCER; ENDOSCOPY; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGENS;

EID: 0030041356     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Marshall BJ y Warren JR. Unidentified curved bacilli in the stomach of patiens with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1314.
2. Isenberg JI, McQuaid KR, Laine L y Rubin W. Acid-peptic disorders. En: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE eds. Textbook of Gastroenterology, vol 1. Philadelphia: JB Lippincott, 1991: 1241-1339.
3. Rotter JI y Rimoin DL. Peptic ulcer disease - a heterogeneus group of disorders? Gastroenterology 1977; 73: 604-608.
4. Rotter JI, Petersen G, Samloff et al. Genetic heterogenity of hiperpepsinogenemic I and normopepsinogenemic I duodenal ulcer disease. Ann Intern Med 1979; 91: 372-376.
5. Rotter JI, Sones JQ, Samloff IM et al Duodenal ulcer disease associated with elevated serum pepsinogen I. An inherited autosomal dominant disorder. N Eng J Med 1979; 300: 63-66.
6. Oderda G, Dell'Olio D, Lerro P. Altare F. Moora I y Ansaldi N. Campylobacter pylori and serum pepsinogen I in children. Gut 1988; 29: A1460.
7. Oderda G, Vaira D, Holton J, Ainley C, Altare F y Ansaldi N. Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet 1989; 1: 690-692.
8. Oderda G, Vaira D, Holton J, Dowsett JF y Ansaldi N. Serum pepsinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood. Gut 1989; 30: 912-916.
9. Oderda G, Vaira D, Dell'Olio D et al. Serum pepsinogen I and gastrin concentrations in children positive for Helicobacter pylori. J Clin Pathol 1990; 43: 762-765.
10. Hengels KJ, Jablonowski K, Schumacher B et al. Serum pepsinogens: sensitive indicators of gastritis activity. Rev Esp Enf Dig 1990; 78 (suppl. 1): 79.
11. Chittajallu RS, Dorrian CA, Ardill JE y McColl KE. Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 1992; 27: 20-23.
12. Veenendaal RA, Biemond I, Peña AS, Duijn W Van, Kreuning J y Lamers CPHW. Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut 1992; 33: 452-455.
13. Fraser AG, Prewett EJ, Pounder RE y Samloff IM. Twenty-four-hour hyperpepsinogenaemia in Helicobacter pylori-positive, subjets is abolished by eradication of the infection. Aliment Pharmacol Ther 1992; 6: 389-391.
14. Asaka M, Kimura T, Kudo M et al. Relationship for Helicobacter pylori to serum pepsinogen in a asyntomatic Japanese population. Gastroenterology 1992, 102: 760-763.
15. Mossi S, Meyer-Wyss B, Rener EL, Merki HS, Gamboni G y Beglinger C. Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjets without symptoms and patients with duodenal ulcer. Gut 1993; 34: 752-754.
16. Wagner S, Haruma K, Gladziwa U et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroenterol 1994; 89: 1211-1217.
17. McNuIty CAM y Watson DM. Spiral bacteria of the gastric antrum. Lancet 1984; i: 1068-1073.
18. Marshall BJ, McGechie DB, Rogers PA y Glancy RJ. Pyloric campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142: 439-444.
19. Humphreys H, Bourke S, Dooley C et al. Effect of treatment on Campylobacter pylori in peptic disease a randomised prospective trial. Gut 1988; 29: 279-283.
20. Dooley CP y Cohen H. The clinical significance of Campylobacter pylon. Ann Intern Med 1988; 108: 70-79.
21. Samloff IM y Taggart RT. Pepsinogens, pepsins and peptic ulcer. Clin Invest Med 1987; 10: 215-220.
22. Jones DM, Eldridge J, Fox AJ, Sethi P y Whorwell PJ. Antibody to the gastric Campylobacter-like organism ("Campylobacter pyloridis"). Clinical correlations and distribution in the normal population. J Med Microbiol 1986; 22: 57-62.
23. Megraud F, Brassens-Rabbe MP y Denis F. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiolog 1989; 27: 1870-1873.
24. Sainz S, Mirelis B, González D, Sancho FJ y Monés J. Diagnóstico de la infeccion por Campylobacter pylori en la mucosa gástrica: aspectos histológicos y microbiológicos. Med Clin (Barc) 1990; 94: 561-563.
25. Monés J, Sainz S, Carrió I, Berna LI, Sancho FJ y Vilardell F. Dispepsia funcional, vaciado gástrico de sólidos e infeccion por Helicobacter pylori. Rev Esp Enf Digest 1994; 85: 325-330.
26. Gisbert JP, Boixeda D, Vila T et al. Descenso de los niveles basales de gastrina tras la erradicacion de Helicobacter pylori. Rev Esp Enferm Dig 1995; 87: 99-107.
27. Gisbert JP, Boixeda D, De Rafael L et al. ¿De qué factures depende el ćxito de la triple terapia "clásica" en la erradicación de Helicobacter pylori? Rev Esp Enferm Dig. En prensa.
28. Gisbert JP, Boixeda D, Redondo C et al. Prueba del aliento para el diagnóstico de infección por Helicobacter pylori: concordancia con los métodos histológicos y correlación con las lesiones anatomopatológicas de la mucosa gástrica. Rev Esp Enferm Dig. En prensa.
29. Tytgat GNJ, Lee A, Graham DY, Dixon MF y Rokkas T. The role of infectious agents in peptic ulcer disease. Gastroenterol Int 1993; 6: 76-79.
30. Rangachari PK. Helicobacter pylori and hypergastrinemia: the quisling option. Scand J Gastroenterol 1991; 26 (suppl. 187): 85-89.
31. Sainz R, Montoro M y Gomollón F. Ulcera duodenal. En: Vilardel F, Rodés J, Malagelada SR, Moreno E, Pajares JM, Pérez Mota A y Puig la Calle J. Enfermedades Digestivas. Ediciones CEA. Madrid 1990: 721-744.
32. Oderda G, Vaira D, Holton J et al. Helicobacter pylori in children with peptic ulcer and their families. Dig Dis Sci 1991; 36: 572-576.
33. Gonzalo MA, Alvarez de Mon, M, Rossi I. Albillos A y Abreu L. Heterogeneidad fisiológica de los pacientes con enfermedad ulcerosa duodenal en relacíon con la edad. II curso de actualización en gastroenterología y hepatología. J. Rodés y C. Chantar, J. R Prous Editores, 1989: 75-80.
34. Chittajallu RS, Ardill JES y McColl Kel. The degree of hypergastrinaemia induced by Helicobacter pylori is the same in duodenal ulcer and asymptomatic volunteers. Eur J Gastroenterol Hepatol 1993; 4: 49-52.
35. Gisbert JP, Boixeda D, Vila T, Cantón, R, Alvarez Baleriola I y Martín de Argua C. Infección por Helicobacter pylori y concentraciones basales de gastrina sérica en pacientes ulcerosos duodenales y con endoscopia normal. Med Clin (Barc). En prensa.
36. Ichinose M, Miki K, Furhata C et al. Radioimmunoassay of serum group I and group II pepsingens in normal controls and patients with various disorders. Clin Chim Acta 1982; 126: 183-191.
37. Malesci A, Basilico M y Bersani M. Serum pepsinogen I elevation in cigarette smokers. Scand J Gastroenterol 1988; 23: 602-606.
38. Plebani M, Delle Fabe OF, Annibale B et al. Pepsinogens A and C are related to Helicobacter pylori infection. Gastroenterology 1992; 104: A40.
39. Cheng TS, Tsay SH, Chang FY y Lee SD. Effect of eradication on Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients; a 12-month follow-up study. Am J Gastroenterol 1994; 89: 1511-1514.
40. Boixeda D, Gisbert JP, Vila T et al. Descenso de los niveles basales de pepsinógeno I sérico tras la erradicación de Helicobacter pylori. Rev Clin Esp 1995; 195: 214-219.
41. Hunter FM, Corea P, Fontham E, Ruiz B, Sobhan M y Samloff M. Serum pepsinogens as markers of response to therapy for Helicobacter pylon gastritis. Dig Dix Sci 1993; 38: 2081-2085.
42. McColl KEL, Nujumi AM, Dorrian CA, MacDonald AM, Fullarton GM y Harwood J. Helicobacter pylori and hypergastrinaemia during proton pump inhibitor therapy. Scand J Gastroenterol 1992; 27: 93-96.
43. Waldum HL, Burhol PG y Straume BK. Serum group I pepsinogens during prolonged infusion of pentagastrin and secretin in man. Scand J Gastroenterol 1979; 14: 761.
44. Albillos A, Alvarez-Mon M, Rossi I, Gonzalo MA, Marin MC y Abreu L. Different HCl and pepsinogen I secretion patterns in anatomically defined gastric ulcer subsets. Am J Gastroenterol 1990; 85: 535-538.
45. Cave TR y Cave DR. A Helicobacter pylori peptide increases pepsinogen secretion from isolated rabbit gastric glands. Rev Esp Enf Dig 1990; 78 (suppl. 1): 52-54.